We have a rich history in evidence-based research and development including partnering with the DoD through 8 research contracts. BrainScope has invested $100 million over 12 years in R&D in support of our highly validated technology with 8 FDA clearances, 32 peer-reviewed clinical publications about BrainScope, and over 14,000 subject evaluations. Rapid, objective patient assessment is our highest priority.
Note: Specific disclosures on this page clearly identify proposed uses that are outside cleared indications of BrainScope. Please contact us for more complete labeling.
179(11):1250-1253. DOI: 10.5811/westjem.2018.5.37293